Viking Therapeutics Inc (VKTX)

[greens12]

VKTX P2 study had better results than MDGL. 91% of VKTX patients had 30% liver fat reduction while MDGL had only 60% patients with 30% reduction. VKTX has a better drug than MDGL

http://ir.vikingtherapeutics.com/2018-11-12-Viking-Therapeutics-Presents-Results-from-Phase-2-Study-of-VK2809-in-Patients-with-Non-Alcoholic-Fatty-Liver-Disease-NAFLD-and-Elevated-LDL-Cholesterol-in-Oral-Late-Breaker-Presentation-at-The-Liver-Meeting-R-2018